Cabotinib is a multi-target anti-tumor drug. Generally, there are 1-3 tumor targets, while Cabotinib has more than 9 targets, mainly targeting RET, ROS1 and other related targets. Cabotinib can be used in many kinds of tumors, including lung cancer, liver cancer, thyroid cancer, etc. Cabotinib is not the first choice for the treatment of lung cancer, generally through gene testing. Cabotinib is not used very much in clinical practice, such as apatinib and arrotinib.
| Product name |
Cabozantinib |
| Appearance |
white Powder |
| Specification |
99% |
| Shelf life |
2 years when properly stored |
A
Function and Application
Cabozantinib is used for medullary thyroid carcinoma and advanced renal cell carcinoma in people who have previously received anti-angiogenic therapy.
Currently, it is undergoing clinical trials to treat prostate cancer, bladder cancer, ovarian cancer, brain cancer, melanoma, breast cancer, non-small cell lung cancer, pancreatic cancer and hepatocellular carcinoma.
?
Frequently Asked Questions
What is the purity of this Cabozantinib powder?
The product features a high purity level of over 99%, ensuring its suitability for research and professional applications.
What are the main therapeutic targets of Cabozantinib?
Cabozantinib is a multi-target drug that primarily targets RET, ROS1, and several other related tumor pathways.
Which certifications does the product hold?
Our Cabozantinib powder is compliant with GMP, ISO 9001, and USP quality standards.
What is the shelf life and storage requirement?
The shelf life is 2 years when stored properly in a cool, dry place away from direct light.
What is the Minimum Order Quantity (MOQ)?
The standard MOQ for this product is 1kg, and samples are available for quality testing.
How is the product packaged for international transport?
We provide secure packaging in either 1kg aluminum foil bags or 25kg drums to ensure product stability during transit.